摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-amino-7-(2'-deoxy-β-D-erythro-pentofuranosyl)-3,7-dihydro-2H-pyrrolo<2,3-d>pyrimidin-2-one | 103173-80-4

中文名称
——
中文别名
——
英文名称
4-amino-7-(2'-deoxy-β-D-erythro-pentofuranosyl)-3,7-dihydro-2H-pyrrolo<2,3-d>pyrimidin-2-one
英文别名
4-amino-7-(2-deoxy-β-D-erythro-pentofuranosyl)-1,7-dihydro-2H-pyrrolo[2,3-d]pyrimidin-2-one;7-deaza-2'-deoxyisoguanosine;4-amino-7-(2'-deoxy-β-D-erythro-pentofuranosyl)-3,7-dihydro-2H-pyrrolo[2,3-d]pyrimidin-2-one;4-Amino-7-(2-deoxy-b-D-ribofuranosyl)-1,7-dihydro-2H-pyrrolo[2,3-d]pyrimidin-2-one;4-amino-7-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-pyrrolo[2,3-d]pyrimidin-2-one
4-amino-7-(2'-deoxy-β-D-erythro-pentofuranosyl)-3,7-dihydro-2H-pyrrolo<2,3-d>pyrimidin-2-one化学式
CAS
103173-80-4
化学式
C11H14N4O4
mdl
——
分子量
266.257
InChiKey
KRCGKJZLLPGTBU-XLPZGREQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    188-192 °C(Solv: ethanol (64-17-5))
  • 密度:
    1.90±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -1.6
  • 重原子数:
    19
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    120
  • 氢给体数:
    4
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-amino-7-(2'-deoxy-β-D-erythro-pentofuranosyl)-3,7-dihydro-2H-pyrrolo<2,3-d>pyrimidin-2-one 生成 Diphenyl-carbamic acid 4-(dibutylamino-methyleneamino)-7-((2R,4S,5R)-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl ester
    参考文献:
    名称:
    Parallel-Stranded DNA Formed by New Base Pairs Related to the Isoguanine-Cytosine or Isocytosine-Guanine Motifs
    摘要:
    Parallel-stranded (ps) oligonucleotide duplexes containing several new base pairs formed between 7-deazaisoguanine and cytosine, 8-aza-7-deaza-isoguanine and cytosine, and 5-aza-7-deaza guanine and guanine are described. The stability of the ps-hybrids increased if the duplex contains 8-aza-7-deazaisoguanine instead of isoguanine and is decreased by 7-deazaisoguanine incorporation. The purine-purine base pair between 5-aza-7-deazaguanine and guanine was found to be more stable than that of 5-methylisocytosine with guanine.
    DOI:
    10.1080/07328319908044781
  • 作为产物:
    参考文献:
    名称:
    Artificial Genetic Systems:  Exploiting the “Aromaticity” Formalism To Improve the Tautomeric Ratio for Isoguanosine Derivatives
    摘要:
    The tautomerism of 2'-deoxy-7-deaza-isoguanosine (2) was studied and compared to that of 2'-deoxyisoguanosine (1). The fixed N-1-methyl (8) and O-methyl (4) derivatives were synthesized to represent the pure extremes of each tautomer. The replacement of the imidazole ring in 1 with a pyrrole ring in 2 makes the keto form in the latter more favored by 2 orders of magnitude (K-TAUT for 2 approximate to 10(3), as opposed to K-TAUT for 1 approximate to 10).
    DOI:
    10.1021/jo0497959
点击查看最新优质反应信息

文献信息

  • Base-Pairing, Tautomerism, and Mismatch Discrimination of 7-Halogenated 7-Deaza-2‘-deoxyisoguanosine:  Oligonucleotide Duplexes with Parallel and Antiparallel Chain Orientation
    作者:Frank Seela、Xiaohua Peng、Hong Li
    DOI:10.1021/ja0425785
    日期:2005.6.1
    Oligonucleotides containing 2'-deoxyisoguanosine (1, iG(d)), 7-deaza-2'-deoxyisoguanosine (2, c(7)iG(d)), and its 7-halogenated derivatives 3 and 4 were synthesized on solid phase using the phosphoramidite building blocks 5-7. The hybridization properties of oligonucleotides were studied on duplexes with parallel and antiparallel chain orientation. It was found that the 7-halogenated nucleoside analogues
    在固相上合成含有 2'-脱氧异鸟苷 (1, iG(d))、7-deaza-2'-deoxyisoguanosine (2, c(7)iG(d)) 及其 7-卤代衍生物 3 和 4 的寡核苷酸使用亚磷酰胺积木 5-7。在具有平行和反平行链方向的双链体上研究了寡核苷酸的杂交特性。发现 7-卤代核苷类似物 3 和 4 显着增强了平行 (ps) 和反平行 (aps) DNA 中的双链体稳定性。此外,卤化核苷将互变异构酮-烯醇平衡强烈地转向酮形式,K(TAUT) [酮]/[烯醇] 大约 10(4) 接近 2'-脱氧鸟苷 (10(4)- 10(5)),而非卤化的 7-deaza-2' -脱氧异鸟苷 2 的 K(TAUT) 约为 2000,1 的烯醇浓度在水溶液中为 10%。因此,在反平行和平行 DNA 中,核苷 3 和 4 对 dT 的错配辨别能力比化合物 1 或 2 好得多。与 1 或 2 相比,预期
  • 2?-Deoxyisoguanosine and Base-Modified Analogues: Chemical and Photochemical Synthesis
    作者:Zygmunt Kazimierczuk、Ralf Mertens、Wieslaw Kawczynski、Frank Seela
    DOI:10.1002/hlca.19910740816
    日期:1991.12.11
    synthesis of 2′-deoxyisoguanosine (2), and the pyrrolo[2,3-d]pyrimidine and pyrazolo[3,4-d]pyrimidine 2′-deoxyribonucleosides 3 and 4 is described. Condensation of the imidazole precursor 5 with benzoyl isocyanate followed by reaction with ammonia gave 2. Its N(7) regioisomer was obtained from 6. Compound 2 was also prepared by the photochemically induced conversion of 2-Chloro- and 2-bromopurine 2′-deoxyribofuranosides
    描述了2'-脱氧异鸟苷(2),吡咯并[2,3- d ]嘧啶和吡唑并[3,4- d ]嘧啶2'-脱氧核糖核苷3和4的合成。咪唑前体5与苯甲酰基异氰酸酯缩合,然后与氨反应,得到2。它的N(7)区域异构体是从6获得的。还通过分别在水溶液中将2-氯-和2-溴嘌呤2'-脱氧核糖呋喃糖苷9a和10进行光化学诱导的转化来制备化合物2,进一步将光反应用于化合物3的合成。和4分别从氨基-氯-2'-脱氧核苷9b和9c开始。
  • Furanoside–pyranoside isomerization of tubercidin and its 2′-deoxy derivatives: influence of nucleobase and sugar structure on the proton-catalysed reaction
    作者:Frank Seela、Sabine Menkhoff、Silvia Behrendt
    DOI:10.1039/p29860000525
    日期:——
    2′-Deoxy-2-methoxytubercidin (6a) which was prepared from the nucleobase (1a) with the halogenose (2)via phase-transfer glycosylation isomerizes rapidly under acidic conditions. Two pyranosides [(7a) and (8a)] and the anomeric furanoside (5a) are formed. The isomerization process was followed kinetically, demonstrating that furanoside formation is kinetically controlled whereas the β-pyranoside (7a)
    由核苷碱基(1a)与卤代糖(2)经由相转移糖基化反应制得的2'-脱氧-2-甲氧基微球蛋白(6a)在酸性条件下迅速异构化。形成两个吡喃糖苷[((7a)和(8a)]]和异头呋喃糖苷(5a)。动力学上遵循异构化过程,表明呋喃糖苷的形成在动力学上受到控制,而β-吡喃糖苷(7a)是热力学上最稳定的产物。与(6a)相比,从2'-脱氧结核菌素(6b)获得了相似的结果,但异构化较慢。核糖核苷结核菌素(6c)仅在强酸处理下才异构化,通过裂解N-糖基键产生α-呋喃糖苷(5c)和核碱基(1c)。
  • 7-Deazaisoguanine quartets: self-assembled oligonucleotides lacking the Hoogsteen motif
    作者:Frank Seela
    DOI:10.1039/a704866a
    日期:——
    Oligonucleotides containing consecutive 7-deazaisoguanine residues form self-assembled quartets, indicating that the purine nitrogen-7 of isoguanine is not participating in the hydrogen bonding pattern.
    含有连续 7-去氮异鸟嘌呤残基的寡核苷酸形成了自组装四元组,表明异鸟嘌呤的嘌呤氮-7 没有参与氢键模式。
  • Molecular recognition systems with pyrimidine analog pairing
    申请人:Hoshika Shuichi
    公开号:US10370706B1
    公开(公告)日:2019-08-06
    This invention covers a new molecular recognition system, where duplexes of DNA-like molecules comprise segments built from nucleotides that carry only a small pyrimidine-like analog, and where the segments pair by pyrimidine analog:pyrimidine analog “skinny” pairing. This pairing retains hydrogen bonding complementarity. Further, this invention relates to processes for preparing those duplexes, and processes that use such duplexes as primer:template complexes for reactions catalyzed by DNA polymerases.
    本发明涉及一种新的分子识别系统,在这种系统中,DNA 样分子的双链包括由核苷酸构建的片段,这些核苷酸只携带一种小的嘧啶类似物,这些片段通过嘧啶类似物:嘧啶类似物的 "瘦 "配对配对。这种配对保留了氢键互补性。此外,本发明还涉及制备这些双链体的工艺,以及将这些双链体用作 DNA 聚合酶催化反应的引物:模板复合物的工艺。
查看更多

同类化合物

(2R,3S,5R)-5-(4-氨基-7H-吡咯[2,3-D]嘧啶-7-基-2 -(羟甲基)四氢呋喃-3-醇 鲁索替尼 鲁索利尼杂质C 迪高替尼 诺那吡胺 螺[4.4]壬烷-1-酮,6-氨基-,(5S,6S)- 苯酚,2,4-二氯-5-肼-,单盐酸 苯并呋喃,2,3-二氢-3-(1-甲基乙基)- 聚(氧代-1,2-乙二基),a-甲基-w-[[3,4,4,4-四氟-2-[1,2,2,2-四氟-1-(三氟甲基)乙基]-1,3-二(三氟甲基)-1-丁烯-1-基]氧代]- 维贝格龙 磷酸鲁索替尼 甲基7-(2-甲氧基乙基)-1,3-二甲基-2,4-二羰基-2,3,4,7-四氢-1H-吡咯并[2,3-D]嘧啶-6-羧酸酯 托法替尼杂质28 托法替尼杂质2 托伐替尼杂质T 异丙基2-氨基-4-甲氧基-7h-吡咯并[2,3-d]嘧啶-6-羧酸 巴里替尼杂质5 巴瑞替尼 巴瑞克替尼杂质 巴瑞克替尼中间体3 巴瑞克替尼中间体1 外消旋鲁替替尼-d8 培美酸 吡啶,1-[(2,5-二甲基苯基)甲基]-1,2,3,6-四氢- 吡咯并[1,2-a]嘧啶-3-羧酸 吡咯并[1,2-F]嘧啶-3-甲酸乙酯 吡咯并[1,2-A]嘧啶-6-羧酸 吡咯并[1,2-A]嘧啶-6-甲醛 叔丁基2-氨基-4-氯-5H-吡咯并[3,4-D]嘧啶-6(7H)-羧酸酯 叔丁基-4-氯-2-吗啉代-7H-吡咯并[2,3-D]嘧啶-7-甲酸甲酯 十二烷-1,12-二基二(苯甲基二甲基铵)二氯化 亚乙基,2-氨基-1-(乙酯基<乙氧羰基>)-2-(甲酰基亚氨基)-,(2Z)-(9CI) 二环[2.2.1]庚-5-烯-2-羧酸,丁基酯,(1R,2R,4R)- [4-(1H-吡唑-4-基)-7H-吡咯并[2,3-D]嘧啶-7-基]甲基特戊酸酯 [3-(4-氨基-7H-吡咯并[2,3-d]嘧啶-7-基)环戊基]甲醇 [1-(乙基磺酰基)-3-[4-(7H-吡咯并[2,3-d]嘧啶-4-基)-1H-吡唑-1-基]氮杂环丁烷-3-基]乙腈磷酸盐 S-鲁索替尼 PF-04965842(阿布罗替尼) N-苯基-5H-吡咯并(3,2-d)嘧啶-4-胺 N-苄基-7H-吡咯并[2,3-d]嘧啶-4-胺 N-苄基-5H-吡咯并[3,2-d]嘧啶-4-胺 N-甲基-N-((3S,4S)-4-甲基哌啶-3-基)-7H-吡咯并[2,3-D]嘧啶-4-胺 N-甲基-N-((3R,4R)-4-甲基哌啶-3-基)-7H-吡咯并[2,3-D]嘧啶-4-胺 N-甲基-7h-吡咯并[2,3-d]嘧啶-4-胺 N-甲基-1-((1R,4R)-4-(甲基(7H吡咯[2,3-D]嘧啶-4-基)氨基)环己基)甲磺酰胺富马酸甲酯 N-(5-溴-4-氯-7H-吡咯并[2,3-d]嘧啶-2-基)-2,2-二甲基-丙酰胺 N-(4-甲氧基苯基)-5H-吡咯并(3,2-d)嘧啶-4-胺 N-(4-氯-7H-吡咯并[2,3-D]嘧啶-2-基)-2,2-二甲基丙酰胺 N-(4-氯-5-碘-7H-吡咯[2,3-D]嘧啶-2-基)-2,2-二甲基丙酰胺 N-(4-氯-5-氰基-7H-吡咯并[2,3-d]嘧啶-2-基)-2,2-二甲基丙酰胺